For the last six years, Idervan DaCosta has endured shortness of breath and pain in his lungs that feels like they are on fire. This happens every couple of months and lasts a few weeks at a time. DaCosta attributes it to inhaling toxins while sleeping yards away from burn pits in Afghanistan. But the U.S. Department of Veterans Affairs (VA) denied his application for disability benefits for the condition. Now, the Marine veteran and Brookfield resident has more hope.
Debra Geske, a Navy technician, was enjoying cranberry juice at a bar in Guam when a male sailor spiked it with a drug when she wasn’t looking. He and two other sailors drove her home and raped her. “I woke up the next morning full of blood,” she said. When Geske reported the rape to her petty officer in 2000, he said he couldn’t respond until higher-ups arrived on a Navy ship four weeks later. Then, officials told her it was a “he said she said” scenario, and “they did nothing,” she said.
More than 60 medical experts, state health directors and advocacy groups have asked federal Medicare officials to remove questions related to pain treatment from hospital patient surveys that are used to rate hospital quality, saying such questions “have had the unintended consequence of encouraging aggressive opioid use in hospitalized patients and upon discharge.”
In a letter to Andy Slavitt, acting administrator of the Centers for Medicare & Medicaid Services (CMS), the group said “aggressive management of pain should not be equated with quality healthcare, as it can result in unhelpful and unsafe treatment, the end point of which is often the inappropriate provision of opioids.” The coalition asked that CMS survey questions such as “During this hospital stay, how often was your pain well controlled?” be removed. The group sent a similar letter to the Joint Commission, which accredits U.S. hospitals, asking that it revise its pain management standards – specifically, guidelines directing doctors to ask patients to assess their pain, as they assess other “vital signs.”
“Mandating routine pain assessments for all patients in all settings is unwarranted and can lead to overtreatment and overuse of opioid analgesics,” they wrote. The letters come as Connecticut and other states grapple with a surge in opioid-related overdoses. Last week, U.S. Sen. Richard Blumenthal, D-Conn., joined several other senators to support a bill that would factor-out the pain-related questions on patient surveys from hospitals’ Medicare reimbursement determinations. Meanwhile, at the state legislature, the Public Health Committee has proposed a bill that would cap initial prescriptions of opioids to seven days for acute pain.
A U.S. Army veteran found dead in a public bathroom at the Veterans Affairs Hospital in West Haven died of accidental heroin intoxication, according to Dr. James R. Gill, the state medical examiner. Zachary Paul-Allen Greenough, 28, of Uncasville, was participating in a residential program where he was free to leave the hospital campus during the day, according to Pamela Redmond, spokesperson for the West Haven VA hospital. She said, as a result, Greenough could have obtained the drugs “anywhere.”
She said the VA would not comment on the cause of Greenough’s death, which occurred on Dec. 22, 2015. She said an investigation by the hospital’s Patient Safety Program has been completed, but the results are not yet available.
Veterans’ exposure to toxic chemicals may harm their families’ health for generations, causing cancer, birth defects and other medical problems, according to U.S. Sen. Richard Blumenthal. He is co-sponsoring legislation to require that veterans be informed of their exposure to toxic substances and to establish a research center focusing on the illnesses of exposed veterans’ descendants. Blumenthal, the ranking Democrat on the Senate Veterans Affairs Committee, said that “the dimensions of the problem are unknown at this point” because no one has collected data on it. But, he added, “we know the toxic exposure is there. Science indicates it can cause genetic effects.” He cited brain and blood cancers as potential repercussions.